FDA inspection
OMRIX Biopharmaceuticals Ltd.: FDA inspection ending Feb 24, 2020
FDA inspection 1119387 · Voluntary Action Indicated (VAI) · Ramat Gan
Key facts
| Inspection ID | 1119387 |
|---|---|
| Firm | OMRIX Biopharmaceuticals Ltd. |
| FEI number | 3003183625 |
| Address | Mda Blood Services Center, Sheba Medical Center |
| City | Ramat Gan |
| Country | Israel |
| Fiscal year | 2020 |
| Inspection end date | Feb 24, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data